Inveready, a venture capital management firm and CataloniaBio & HealthTech member, has registered a €20-million fund called Inveready Alternative Markets (ALMA) with the Spanish National Securities Market Commission (CNMV) to invest in alternative markets in Europe.

The new vehicle will invest between €1 million and €2 million in companies traded on the BME Growth, Euronext Growth, AIM Italia and AIM London markets.

Inveready is the main institutional investor in success stories such as Atrys Health, MásMóvil, Gigas Hosting, VozTelecom and Agile Content.

More information

Photo: Rubén González, director of the new fund ALMA - © Inveready

You may also be interested in:

• Inveready liquidates first fund with return of €100 million
• Inveready sets up €110-million fund for growing SMEs
• Inveready launches First III fund with €54 million